An update on antifungal targets and mechanisms of resistance in Candida albicans.
about
Induced production of antifungal naphthoquinones in the pitchers of the carnivorous plant Nepenthes khasianaCryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomesGene annotation and drug target discovery in Candida albicans with a tagged transposon mutant collectionIdentification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assayCharacterization of the chromosome 4 genes that affect fluconazole-induced disomy formation in Cryptococcus neoformansEssential roles of the Kar2/BiP molecular chaperone downstream of the UPR pathway in Cryptococcus neoformansGlutathione metabolism in Candida albicans resistant strains to fluconazole and micafunginInhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole ResistanceAn Optimized Lock Solution Containing Micafungin, Ethanol and Doxycycline Inhibits Candida albicans and Mixed C. albicans - Staphyloccoccus aureus BiofilmsMitochondrial Complex I Is a Global Regulator of Secondary Metabolism, Virulence and Azole Sensitivity in FungiRapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing.Changes in the proteome of Candida albicans in response to azole, polyene, and echinocandin antifungal agents.2-Amino-nonyl-6-methoxyl-tetralin muriate inhibits sterol C-14 reductase in the ergosterol biosynthetic pathway.Fungal PDR transporters: Phylogeny, topology, motifs and function.A histone deacetylase complex mediates biofilm dispersal and drug resistance in Candida albicans.Candida infections and their prevention.Caenorhabditis elegans-based model systems for antifungal drug discovery.Effective photosensitization and selectivity in vivo of Candida Albicans by meso-tetra (N-methyl-4-pyridyl) porphine tetra tosylateModulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategyA universal TagModule collection for parallel genetic analysis of microorganisms.In vivo systematic analysis of Candida albicans Zn2-Cys6 transcription factors mutants for mice organ colonization.Comparison of human and soil Candida tropicalis isolates with reduced susceptibility to fluconazoleSertaconazole: an antifungal agent for the topical treatment of superficial candidiasis.RNA sequencing revealed novel actors of the acquisition of drug resistance in Candida albicans.A small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes.Transcriptional profile of Paracoccidioides spp. in response to itraconazoleBiofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity.Miconazole induces fungistasis and increases killing of Candida albicans subjected to photodynamic therapyFungal biofilm resistance.Involvement of PDK1, PKC and TOR signalling pathways in basal fluconazole tolerance in Cryptococcus neoformans.Role for cell density in antifungal drug resistance in Candida albicans biofilmsGenotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates.Cryptococcus neoformans Yop1 , an endoplasmic reticulum curvature-stabilizing protein, participates with Sey1 in influencing fluconazole-induced disomy formationA new, broad-spectrum azole antifungal: posaconazole--mechanisms of action and resistance, spectrum of activity.A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate.Posaconazole: a new broad-spectrum antifungal agent.Stimulation of superoxide production increases fungicidal action of miconazole against Candida albicans biofilmsPosaconazole in the management of refractory invasive fungal infections.Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance
P2860
Q24655345-B56683F6-D2BA-4084-9AAF-09CCD1250169Q27315103-8DC10C5D-4357-4DBA-9FC5-C369264C6DF4Q28475711-376F7399-3ECF-4B98-A86D-4A27AFE7CCAEQ28476138-691DA67A-3AAC-4838-8ECF-F4EB47642899Q28481426-576A360E-F7CF-40A8-A61C-2D485D5B03F1Q28487703-050D5BAE-136E-4EDA-9DE9-84898A81912AQ28539336-D88BE7DB-F9B4-4F34-A106-C901966FF314Q28547078-61D245A5-12FA-43C9-B0B0-3E1C8DCCE168Q28552679-7C0267D2-AEA4-4676-86D2-5AA27BACB9EAQ28552733-016B6463-B7ED-4EA9-8AC5-F2D6A36DF3EBQ33493582-FFFB61DB-A1A6-46F8-832B-4E83003FD7B6Q33530441-B0B8B5F6-9067-4B28-9B8E-D6C1E27A4F28Q33556437-23A30449-BD10-48E4-A6B0-CB40E0131547Q33624643-9B575ED0-6426-4198-AE11-B0C2758F9B54Q33751845-FC3E5352-F6E1-4EDA-9E78-3F1C980FDF3FQ33775256-1D2F60B9-A2A1-4AE2-9617-A4504A3DA08DQ33864072-BA921BB6-4AB5-4D57-91EE-A6F21538A457Q33875368-79DCB976-C55A-4492-9C87-9A500CF41B31Q33940382-C47A0C11-2007-4CE8-A577-3AC68A831A39Q34058413-D4C3ACB7-2739-4961-999A-FCED688B1331Q34071444-13A79563-8089-48DA-B0C6-16168D5F0313Q34230214-9258ABC0-35B5-4A69-9642-C611ED0DDE5FQ34337801-8650C47A-4FFD-406F-A684-ACBE53813CE4Q34381656-2575CBEA-02C2-4848-BA49-F0E1A5095193Q35127891-CDF61DE5-2044-4279-818B-C5ADE73AAB22Q35137086-E59795B9-9452-4BC5-9D5C-8D60604C2A17Q35201457-51B4862B-9773-4F65-991E-6D4C38E139ABQ35815540-D8CDD295-E005-4ACA-9C99-1DF98A47C0A9Q35821475-FA3420F5-E119-4EA7-9046-A15F3146B673Q35854764-76FB38D7-F9AA-4CE8-954D-521FA60680E1Q35878982-9E3661A4-5F0D-4C0E-BCDA-D72D015086E6Q36095337-6807BB68-B78F-485E-9374-34D3BDA29B7BQ36319731-5179F030-734E-49BB-9E91-61181BE7B471Q36589292-84AF7991-CDEF-4DFD-A9C5-ABEAB08D99C2Q36746995-F75DE9AF-3518-4A90-A82D-A90D169C3050Q36828159-878F7027-58C0-4698-8198-8070D2B0EA1BQ36974985-C91F2B1E-3182-41B6-B2FB-CCCEAE4181FDQ37052755-A507CF44-55ED-4423-BC0C-1D59CE7D4BF6Q37072109-C7C294B7-20E1-41AE-807A-10C98BE4952CQ37144914-773DE5BF-3F63-45FD-AF12-9022E78F946C
P2860
An update on antifungal targets and mechanisms of resistance in Candida albicans.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
An update on antifungal targets and mechanisms of resistance in Candida albicans.
@ast
An update on antifungal targets and mechanisms of resistance in Candida albicans.
@en
type
label
An update on antifungal targets and mechanisms of resistance in Candida albicans.
@ast
An update on antifungal targets and mechanisms of resistance in Candida albicans.
@en
prefLabel
An update on antifungal targets and mechanisms of resistance in Candida albicans.
@ast
An update on antifungal targets and mechanisms of resistance in Candida albicans.
@en
P2860
P1433
P1476
An update on antifungal targets and mechanisms of resistance in Candida albicans.
@en
P2093
Robert A Akins
P2860
P304
P356
10.1080/13693780500138971
P577
2005-06-01T00:00:00Z